ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Renovacor Inc

Renovacor Inc (RCOR)

3.20
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.20
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
3.20
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

RCOR 最新ニュース

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the treatment of heart conditions Significant unmet...

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus...

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for...

Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research

REN-001 delivered locally via low-dose retrograde coronary sinus infusion demonstrated robust, diffuse cardiomyocyte transduction in a large animal heart Renovacor, Inc. (NYSE: RCOR), a...

Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update

REN-001 advancing toward IND submission in the second half of 2022 with the initiation of a Phase I/II clinical trial in BAG3-DCM expected thereafter Strengthened executive team with appointment...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

RCOR - Frequently Asked Questions (FAQ)

What is the current Renovacor share price?
The current share price of Renovacor is US$ 3.20
What is the 1 year trading range for Renovacor share price?
Renovacor has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
HCWCHealthy Choice Wellness Corp
US$ 1.54
(58.60%)
6.5M
MTNBMatinas Biopharma Holdings Inc
US$ 0.90
(22.62%)
353.95k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 17.74
(20.60%)
22.81M
MSNEmerson Radio Corp
US$ 0.52
(19.51%)
3.89M
MAIAMaia Biotechnology Inc
US$ 2.40
(16.50%)
1.99M
RHERegional Health Properties Inc
US$ 2.37
(-33.43%)
635.48k
SBEVSplash Beverage Group Inc
US$ 0.194
(-28.15%)
4.58M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10.0012
(-20.50%)
46.15M
SYNXSilynxcom Ltd
US$ 4.00
(-18.37%)
46.12k
ETHU2x Ether ETF
US$ 7.955
(-15.46%)
18.56M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.1299
(2.17%)
72.93M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 32.055
(-1.34%)
58.86M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.5006
(7.32%)
50.85M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 2.9071
(9.70%)
45.97M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10.0012
(-20.50%)
45.26M

最近閲覧した銘柄

Delayed Upgrade Clock